The disposition characteristics of biperiden were investigated in rats, rabbits, beagles, and humans, and a physiologically based pharmacokinetic model was established by using the hepatic intrinsic clearance of unbound drug concentration and the tissue-to-plasma unbound concentration ratios. Protein-binding parameters and blood-to-plasma concentration ratios were determined, and linear parameters were obtained in beagles and humans over a wide concentration range. The hepatic intrinsic clearance of humans was predicted from the animal data. The coincidence of each tissue-to-plasma unbound concentration ratio between rats and rabbits was confirmed in the steady state, and the mean tissue-to-plasma unbound concentration ratios were used for the prediction of the plasma concentration-time courses of beagles and humans. The predicted lines fitted the observed plasma concentrations of beagles and a patient well after a single intravenous injection and repeated intramuscular administrations, respectively.
Introduction
Biperiden (BP) is an anticholinergic drug applied in the treatment of parkinsonian syndrome.1) In contrast to the extensive clinical use of BP, knowledge of its pharmacokinetic behavior, metabolism and body distribution in man is still limited. Only two reports of BP serum concentration in man after single oral administration have been made to date,2, 3) while no data are available on serum concentration after repeated parenteral administration of BP in man.
The characteristics of BP pharmacokinetics were thought to be large distribution volume and high plasma clearance in rabbits. 4, 5) In order to predict the plasma concentration in humans from limited data, it is important to use animal data to establish a suitable pharmacokinetic model of BP.
Physiologically based pharmacokinetics have the advantage of interspecies scalability. For the prediction of the intrinsic clearance of an unbound drug in humans, the function of body size of animals was reported to be useful.6) Moreover, it has been claimed that the tissueto-plasma unbound concentration ratios in animals are important to predict the concentrations of several drugs in human plasma :7,8) The purpose of this study was to establish the physiologically based pharmacokinetics of BP by using the hepatic intrinsic clearance of unbound drug and the tissue-to-plasma unbound concentrations. To predict the human plasma concentrations after repeated administrations of BP, the animal data were examined, and the possibilities of animal scale-up are discussed. Table I shows the volume of distribution in the steady state per body weight (Vdss/ BW) and total body plasma clearance per body weight (CLtot/BW) in animals.The values of Vdss/ BW in animals were in the range of 9.5 to 19.3 1/kg, which indicate that extensive tissue distribution of BP is a common characteristic among the tested animals. The value of Vdss/ BW of beagles was about half that of rabbits. The value of CLtot/ BW in the patient was considerably lower than those of rats, rabbits, and beagles. The rank order of CLtot/ BW was: rabbits > rats > beagles > man. Although the values of CL,o,IBW in rats and rabbits could be well explained in terms of hepatic blood flow rate-limited elimination, those of beagles and human were about half of the respective blood flow rate.
Constant serum protein binding and RBP were observed for BP in beagles and humans over a wide BP concentration range (25-10000 ng/ml). All parameters are given in Table II , together with the reported values in rats13) and rabbits.5) Similar RBP values were obtained in animals and in humans. The values of the plasma unbound fraction (fp) in beagles and humans were nearly equal to that of rats, rather than that of rabbits.
The hepatic intrinsic clearance (CLuint , H) of BP was calculated by ( 1 ) where Q1 and ER are hepatic blood flow rate and hepatic extraction ratio, respectively. The calculated values for rats and rabbits are listed in Table II . By assuming that the elimination of BP was occurring only in the liver, the hepatic clearance of BP in beagles was calculated by means of the following equation without the determination of ER. ( 2 ) The calculated value of CLuintm in beagles is listed in Table II . In our previous5) and present experiments on the oral administration of BP in animals, BP was detected in the plasma only in the case of beagles. This may be due to the fact that CLuint, H of beagles was the smallest among the tested animals.
The tissue-to-plasma concentration ratios (Kr) of BP in rabbits were reported pre- Table III . The tissue-to-plasma unbound concentration ratios (K pu) were obtained by dividing the tissue-to-plasma concentration ratio by the value of the serum unbound fraction . The relationship between the Kpu values of BP in rats and rabbits is shown in Fig . 1 . Although the fp value of BP in rats was about one-fourth of that of rabbits, similar Kpuvalues for each tissue were obtained between rats and rabbits. High Kpu values were obtained in lung and adipose tissue. The Kpu values of some viscera, such as the brain, heart, kidney , and gut, were in the range from 50 to 100. Figure 2 shows the physiological pharmacokinetic model utilized here for calculation . This model was built on the basis of the following assumptions: (1) each tissue acts as a wellstirred compartment; (2) BP distribution is blood-flow limited; (3) elimination of BP occurs only from the liver in a linear manner; and (4) the Kpu of BP is independent of the drug concentration. The mass balance equations developed according to the flow diagram in Fig . 2 are given in Appendix II. The mean values of Kpu between rats and rabbits were used to where BW is the standard body weight of animals in kg, and CLuint is the intrinsic clearance of unbound drug in one year. In this analyzing procedure, the values of M LP as reported by Boxenbaum were used.6) The correlation coefficient was high and statistically significant (r = 0.999, p > 0.05). According to the regression parameters , CL.int, H in humans was calculated as listed in Table II . The values of C Luint , H of rats and rabbits were more than 10 times greater than that of humans. Figure 6 shows the predicted and observed plasma concentration profile after intramuscular administrations of BP to the patient. The administration was repeated every 8 h . A previous study carried out at this laboratory5) showed that the absorption from the injection site in the muscle into the systemic circulation was rapid and complete . Moreover, the pharmacokinetics of BP after intravenous injection and intramuscular administration were almost equal in rabbits.5) Thus, the input function in humans was assumed to be equivalent to rapid infusion into the venous plasma. The predicted line agreed well with the observed plasma concentration in the patient. The correlation coefficient was high and statistically significant (r = 0.980, p <0.001).
Discussion
This study demonstrates that a physiologically based pharmacokinetic model based on the hepatic intrinsic clearance of unbound drug and the tissue-to-plasma unbound concentration ratios was applicable to BP.
In our previous studies using the rabbit,5) we have already shown that the high plasma clearance of BP could be well explained in terms of hepatic blood flow rate-limited elimination.
Although the same explanation could be applied to rats, the value of CLt ot/ BW in beagles and humans seemed to be smaller than the hepatic blood flow rate. By using the The model predictions were performed by using the physiological parameters, which were corrected by multiplying by the ratio of actual body weight to standard body weight. r= 0.980. p< 0.001. estimated value of CLuint , H in humans in Table II , the value of CLtut/BW was calculated as 10 ml/min/kg. This value is similar to the observed. CLtut/BW (= 15.3 ml/min/kg) in humans (Table III) . It was reported that no unchanged BP is excreted via the kidney in man.2) In our experiments, the urinary recovery of BP in beagles was almost negligible.( = 0.017% of the administered dose) within 48 h. Thus, it is reasonable to conclude that the route of elimination of intact BP was mainly hepatic elimination, not only in rats and rabbits, but also in beagles and humans. As shown in Table II , humans have a lower capacity for hepatic metabolism of BP. Man's lesser quantitative ability to metabolize appears to apply to many drugs.° Several regression parameters of the allometric exponentials have been reported, i.e., 1.09, 1.23, and 0.922 for antipyrine, phenytoin, and clonazepam, respectively.° The parameter for BP coincides well with these values.
In order to construct a physiologically based pharmacokinetic model using Kpu, the coincidence of the Kpu value of each tissue in several animals must be confirmed. We attempted to establish this most important postulate by using rats and rabbits. This is because the fp value of rabbits was the largest among the animals tested, and rats were suitable and convenient animals for determining the Kpu values. The values of each tissue were in good agreement between rats and rabbits. Recently, Sawada et al.8) reported that, in general, there is little difference between the unbound volume of distribution of various basic drugs in tissues of animals and humans. From the good coincidence in tissue distribution characteristic between rats and rabbits, as shown in Fig. 1 , this generality was confirmed to be applicable to the BP tissue distribution in rats and rabbits. However, the value of Vdss/BW/fp in rats was somewhat larger than that of rabbits. We examined the correlation between Vd ss and fp in animals and humans according to the reported prediction rule of basic drugs.14) The correlation was high, but not significant (r = 0.867). An explanation for this is not yet available.
It is reasonable to assume that the equilibrium conditions in each tissue phase are approached in a simple, linear manner, with characteristic terms determined by tissue volumes and blood flow rates. The assumption of perfusion-limited transport is applicable to lipidsoluble drugs., for which diffusion and movement across lipoid membranes should be relatively rapid. The physiological parameters for a 70-kg human were used as described bofore.11) On this basis, the calculated result is in fair agreement with the observation in the patient given repeated intramuscular administrations.
In conclusion, the physiologically based pharmacokinetic model derived by using the plasma unbound concentration was useful to predict the human plasma concentration. Moreover, the hepatic intrinsic clearance of humans was well explained by the animal data. In the future, in order to clarify the pharmacodynamic action of BP, we can take into account the simulated target tissue concentrations in various disease states by using the present model. b= blood; a = arterial plasma; l= liver; k = kidney; gi = gastrointestinaltract; lu = lung; h= heart; m= muscle; br = brain; f= fat; bo = bone; v = venous; s = skin; t = tissue. 
